ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best drug stocks to buy according to analysts. ANI Pharmaceuticals, Inc ...
Why ANI Pharmaceuticals Stock Is Back on Investors’ Radar ANI Pharmaceuticals (ANIP) has just added two U.S. generics, Pimozide Tablets and Carbamazepine Extended Release Capsules. This gives ...
Zacks Investment Research on MSN
ANI Pharmaceuticals (ANIP) expected to beat earnings estimates: Should you buy?
The market expects ANI Pharmaceuticals (ANIP) to deliver a year-over-year decline in earnings on higher revenues when it ...
ANI Pharmaceuticals ANIP has been steadier than its broader sector this year, but it has not fully kept pace with its closest peer set. Shares are up 2.5% year to date, versus a 3.5% gain for the ...
The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will ...
ANI Pharmaceuticals’ ANIP rare disease franchise spearheaded its growth in 2025. This robust growth was fueled by the strong performance of its ACTH-based injection Cortrophin Gel. Cortrophin Gel ...
ANI Pharmaceuticals’ ANIP rare disease franchise has emerged as a major growth catalyst in 2025, with segment revenues more than doubling year over year to $291 million in the first nine months. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results